NeoGenomics Announces Participation in NCI-MATCH Clinical Trial
24 sept. 2018 07h00 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Sept. 24, 2018 (GLOBE NEWSWIRE) -- NeoGenomics Laboratories, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it is...
NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier
12 sept. 2018 08h14 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Sept. 12, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has been awarded a group...
NeoGenomics Announces Pricing on Public Offering of Common Stock
09 août 2018 20h40 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Aug. 09, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the pricing of its underwritten...
NeoGenomics Announces Proposed Public Offering of Common Stock
06 août 2018 16h19 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Aug. 06, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has commenced an...
NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog
24 juil. 2018 07h00 HE
|
NeoGenomics, Inc.
The Company adopted ASC 606, effective January 1, 2018, using the full retrospective method of adoption. Unless otherwise indicated, all financial results have been restated as if the Company had...
NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018
02 juil. 2018 16h05 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., July 02, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its second...
NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock
25 juin 2018 16h05 HE
|
NeoGenomics, Inc.
Closes on $30 Million Extension to Senior Credit Facility FT. MYERS, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO) (the “Company”), a leading provider of cancer-focused...
PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions
01 juin 2018 08h00 HE
|
NeoGenomics, Inc.
Expanding global oncology testing for clinical trials WILMINGTON, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- Pharmaceutical Product Development, LLC (PPD), a leading global contract research...
NeoGenomics to Participate In Two Upcoming Investor Conferences
25 mai 2018 16h05 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., May 25, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, today announced that company management will be...